Abel Hall LLC’s ReposiTrak TRAK Stock Holding History

Abel Hall LLC’s Portfolio TRAK Stock Details TRAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-13,058	Closed	-$118K	–	1033
2026 Q2	$118K	Buy	+13,058	New	+$119K	0.02%	813

Other funds holding TRAK

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return

Lunt Capital Management Holladay, Utah $263M AUM 6.88% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

LVW Advisors Pittsford, New York $1.19B AUM 19.73% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Abel Hall LLC's TRAK Position: Q3 2026 in Review

Abel Hall LLC sold out of ReposiTrak (TRAK) in Q3 2026, closing a stake of 13,058 shares — an estimated $118K sold.

Abel Hall LLC first reported a position in TRAK in Q2 2026 and held it in 1 quarter. The position peaked at $118K in Q2 2026. 38 funds tracked by Wall St. Rank hold TRAK as of Q3 2026.

Abel Hall LLC reported no remaining ReposiTrak position as of Q3 2026 after selling out during the quarter.
Abel Hall LLC sold 13,058 ReposiTrak shares in Q3 2026, an estimated $118K.
Abel Hall LLC first reported a position in ReposiTrak in Q2 2026 and held it in 1 quarter.
Abel Hall LLC's ReposiTrak position peaked at $118K in Q2 2026.
38 funds tracked by Wall St. Rank held ReposiTrak as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.